Form 8-K - Current report:
SEC Accession No. 0001293971-25-000003
Filing Date
2025-02-20
Accepted
2025-02-20 16:35:15
Documents
13
Period of Report
2025-02-13
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K blue-20250213.htm   iXBRL 8-K 23737
  Complete submission text file 0001293971-25-000003.txt   148232

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20250213.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20250213_lab.xml EX-101.LAB 22783
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20250213_pre.xml EX-101.PRE 13051
15 EXTRACTED XBRL INSTANCE DOCUMENT blue-20250213_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 25646002
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)